Study reveals a causal mechanism for pain reduction may be due to an antibiotic-induced shift in the gut's amino acid concentrations.
Researchers have identified two new species of bacteria in the blood of patients in China. The bacterias are in the Enterobacter genus and are resistant to multiple antibiotics. Enterobacter has previously been linked to meningitis and other serious medical conditions.
Minocycline, a broad-spectrum tetracycline antibiotic, has shown promise in the treatment of depression. Researchers say the antibiotic could help reduce brain inflammation associated with some cases of major depressive disorder. A small study conducted by researchers at Deakin University found those treated with Minocycline reported improved quality of life, reduced anxiety symptoms and a better global impression of their depression.
A synthetic version of a fibupeptide, which is naturally produced by the microbiome, may help in the fight against antibiotic-resistant bacteria. Lugdunin has been shown to be effective against MRSA. The findings could help in the creation of a new class of antibiotics to treat infections currently resistant to drugs on the market.
Mouse study reveals the antibiotic azlocillin completely kills off the Borrelia burgdorferi bacteria at the onset of Lyme disease. Findings also suggest the drug could be effective for treating patients infected with drug-tolerant bacteria that may cause lingering symptoms.
Researchers have identified an association between antibiotics administered to children aged two and under, and an increased risk of ongoing conditions ranging from ADHD to obesity. Children exposed to numerous courses of antibiotics as toddlers were more likely to be diagnosed with continuous conditions later in childhood. The study speculates that while antibiotics may only have a transient effect on the developing microbiome, this may have an impact on long-term illness.
According to researchers, some common antibiotics could be linked to delirium and some other temporary brain problems.
Artificial IntelligenceDeep LearningFeaturedMachine LearningNeurologyNeuroscienceNeurotechOpen Neuroscience Articles··7 min read
A new deep learning algorithm helped researchers identify a powerful new antibiotic compound that kills many of the world's most problematic, disease-causing bacterias, including those which have so far been resistant to common antibiotics.
Early-life exposure to antibiotics could impact brain development in areas associated with emotional and cognitive function, a new study reports. Researchers found penicillin exposure in infant mice altered the microbiome and gene expression in key areas of the developing brain.
Epigallocatechin (EGCG), a natural antioxidant found in green tea, may help in the fight against antibiotic-resistant bacteria. EGCG restores the activity of aztreonam, an antibiotic commonly used to treat infections caused by P. aeruginosa. The bacteria is resistant to major classes of antibiotics and is currently treated with a combination of drugs.
Fluoroquinolone antibiotics, such as Levofloxacin and Ciprofloxacin, appear to increase the risk of peripheral neuropathy by 47%. However, there is no significant increased risk of developing neuropathy associated with amoxicillin use.